Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) (Tonix) is a clinical-stage biopharmaceutical company committed to discovering and developing innovative and proprietary new therapeutics that address the needs of patients. We focus on developing small molecules and biologics to treat CNS (pain, neurology, psychiatry, addiction) and immunological (vaccines, immunosuppression, oncology, autoimmune disease) conditions.
Our mission is to improve the lives of patients by identifying, researching and developing promising therapies which have the potential to address needs not currently fulfilled by existing products.
- Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP) interview with Mr. Seth Lederman, CEO
- New to the Street 241 – October 3rd, 2021 | Hapbee Technologies, Tonix Pharmaceuticals, First Wave BioPharma, GlobeX Data, StrikeForce Technologies, Kylin Network, Sekur
- Tonix Pharmaceuticals CEO Seth Lederman returns to New to the Street
- Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) interview with Mr. Seth Lederman, CEO
- New to the Street | Greene Concepts, GlobeX, Tonix Pharma, Finxflo, GreenBox, Winners Inc., PPJ Healthcare, Snoop Doge, Innerscope Hearing
- Tonix Pharmaceuticals CEO, Seth Lederman, talks about their Company’s pharmaceutical products
- New to the Street – June 20th | Tonix Pharma, Greenbox, GCAC, VegasWinners, Gaensel Energy, MahaDAO, GrapefruitUSA, INND